Medtronic chest compression system cleared
This article was originally published in The Gray Sheet
Executive Summary
Medtronic subsidiary Physio-Control will begin shipping its next-generation Lucas 2 chest compression system in the U.S. this fall, following 510(k) clearance June 23, the firm says. Lucas 2 is an automated, battery-powered device designed to give uninterrupted compressions to patients in cardiac arrest, to facilitate the return of spontaneous circulation. Unlike Lucas 1, Lucas 2 is electric rather than pneumatic. The product is developed and manufactured by Lund, Sweden-based Jolife and distributed in the U.S. by Medtronic/Physio-Control